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ABSTRACT
Aims: The aim of this study was to develop and
implement guidelines for sedation and analgesia
management in the paediatric intensive care unit
(PICU) and evaluate the impact, feasibility and
acceptability of these as part of a programme of
research in this area and as a prelude to future trial
work.
Method: This pilot study used a pre–post design
using a historical control.
Setting: Two PICUs at different hospitals in an
Australian metropolitan city.
Participants: Patients admitted to the PICU and
ventilated for ≥24 h, aged more than 1 month and not
admitted for seizure management or terminal care.
Intervention: Guidelines for sedation and analgesia
management for critically ill children including
algorithm and assessment tools.
Outcome variables: In addition to key outcome
variables (ventilation time, medication dose and
duration, length of stay), feasibility outcomes data
(recruitment, data collection, safety) were evaluated.
Guideline adherence was assessed through chart audit
and staff were surveyed about merit and the use of
guidelines.
Results: The guidelines were trialled for a total of
12 months on 63 patients and variables compared with
the historical control group (n=75). Analysis revealed
differences in median Morphine infusion duration
between groups (pretest 3.63 days (87 h) vs post-test
2.83 days (68 h), p=0.05) and maximum doses
(pretest 120 μg/kg/h vs post-test 97.5 μg/kg/h) with no
apparent change to ventilation duration. Chart audit
revealed varied use of tools, but staff were positive
about the guidelines and their use in practice.
Conclusions: The sedation guidelines impacted on
the duration and dosage of agents without any
apparent impact on ventilation duration or length of
stay. Furthermore, the guidelines appeared to be
feasible and acceptable in clinical practice. The results
of the study have laid the foundation for follow-up
studies in withdrawal from sedation, point prevalence
and longitudinal studies of sedation practices as well
as drug trial work.
INTRODUCTION
Sedation and analgesia are necessary compo-
nents in the care of all critically ill patients,
especially those requiring mechanical ventila-
tion. The main indications for their use
include: to reduce patient pain, anxiety and
agitation, induce amnesia, facilitate mechan-
ical ventilation, prevent the displacement of
endotracheal tubes, and decrease cellular
metabolism.1–3 The detrimental impact of
poor sedation practices intensive care units
(ICUs) has increasingly become a focus for
researcher and clinicians. The impetus for
this stem from concerns about under-sedation
and over-sedation.4 Both under-sedation and
oversedation have the potential to lead to agi-
tated patients with compromised short-term
safety issues and impact on duration of venti-
lation and length of stay (LOS).5 6 The conse-
quences of prolonged use of sedative and
analgesic agents in the ICU patient include
central nervous system activation, gastrointes-
tinal disturbances and sympathetic hyperactiv-
ity. These signs and symptoms have been
related to tolerance and withdrawal phenom-
ena and also hold implications for the
patient’s physical and psychological well-
Strengths and limitations of this study
▪ Detailed outline of the guideline development
process based on the consensus paper and
available evidence.
▪ Original dual site feasibility (pilot) study testing
the impact of guidelines on patient, quality and
practice outcomes.
▪ Generation of clinical and trial process data to
inform future trial work.
▪ No firm evidence or ‘cause and effect’ can be
concluded due to the pre/post study design and
small sample size.
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being as well as healthcare costs.7–9 These risks are poten-
tially ampliﬁed in the critically ill child in the paediatric
ICU (PICU) due to the developing brain.10 11 The aim of
this study was to develop and implement guidelines for
sedation and analgesia management in the PICU and
evaluate the impact, feasibility and acceptability of these
as a part of programme of research in this area and as a
prelude to future trial work.
BACKGROUND
The 2006 consensus guidelines on sedation and anal-
gesia in critically ill children established a standard for
clinical practice in PICUs.12 The guidelines’ key recom-
mendations include advice on a loading dose and
administration for analgesia and sedation medication,
the use of validated pain and sedation assessment tools,
withdrawal assessment, and the inclusion of non-
pharmacological interventions. Surveys of sedation and
analgesia management in PICUs have identiﬁed a lack
of speciﬁc protocols for sedation and analgesia manage-
ment.13–15 This research has also highlighted wide
variations in physician practice, nursing assessment,
pharmacological agents, as well as administrative
methods and doses. Limited use of assessment tools has
also been reported, and there were no measurements or
guidelines for withdrawal of drugs.
A number of studies have attempted to evaluate the
impact of sedation and analgesia guidelines in PICU;
however, the results have been varied.16–20 Each of the
studies successively added to our knowledge and under-
standing of sedation and analgesia management in crit-
ically ill children. However, differences in guideline
speciﬁcs, models of care and study design may have con-
tributed to the varied outcomes observed in the studies
and limited their ability to inform best clinical practice.
The aim of this study was to develop sedation and anal-
gesia management guidelines based on the 2006 consen-
sus recommendation and test their impact on patient
outcomes as well as feasibility and acceptability in prac-
tice as a prelude to rigorous trial evaluation of guide-
lines in practice.
METHODS
Aims and objectives of study
The aim of this study was to develop and implement
guidelines for sedation and analgesia management in
the PICU and, following this, evaluate the impact, and
acceptability and feasibility of their use in the clinical
setting.
Study design
This dual site study used a pragmatic pretest and post-test
design to examine the feasibility and impact of the guide-
lines on patient and practice outcomes. A chart audit was
used to assess the implementation ﬁdelity and a
(nursing) staff survey was conducted to ascertain staff
perceptions of guideline utility and acceptability in prac-
tice. The requirement for consent was waived.
Setting
The study units were two eight-bed, mixed medical–sur-
gical (not cardiac surgery) PICUs located at tertiary
referral children’s hospitals admitting patients from 0 to
16 years of age. Postregistration qualiﬁcations in either
paediatrics, ICU or PICU, were held by approximately
48% of the nursing staff.
Sample and participants
The target population was all patients ventilated for
≥24 h within the PICU, aged more than 1 month and
not admitted for seizure management or terminal care.
All eligible patients were consecutively enrolled into the
study. As the main aim of the study was feasibility and
acceptability of guidelines rather than hypothesis testing,
the statistical power of the sample was of reduced
importance at this stage. Charts of patients in the post-
implementation phase were the focus of the audit. All
nursing staff were invited to participate in the survey
gauging staff perceptions and use of the guidelines in
practice.
Guideline development
The sedation and analgesia guidelines for this study
were developed around an algorithm for each of the
identiﬁed phases of sedation (see online supplementary
appendix 1). The key recommendations of the guide-
lines developed and tested in this study were based on
the key recommendations in the 2006 consensus paper
which are summarised in table 1.12
A range of non-pharmacological strategies to minimise
patient stress and pain and optimise comfort are sup-
ported by varying levels of evidence ranging from case
studies to Cochrane systematic reviews. These were not
new strategies, but it was important to incorporate them
into the guidelines to promote a holistic approach to
pain and sedation management and reﬂect the recom-
mendations of the consensus guidelines. Strategies
recommended were aimed at moderating the PICU
environment where possible (ie, minimising high-
intensity light and noise, ensuring rest periods);21 22
minimising discomfort of invasive devices; regular repo-
sitioning and limb support with pillows, pressure reliev-
ing devices or swaddling;23 24 monitoring and optimising
hydration, nutrition and essential cares (eg, oral and eye
care); supporting parental visitation and reassurance as
well as therapeutic (non-technical) touch.25 26
New assessment scales for behavioural state, pain and
withdrawal assessment were integral to the guidelines.
These included the State Behaviour Scale (SBS),27 28
the Multidisciplinary Assessment of Pain Scale
(MAPS)29–32 and the Opioid Benzodiazepine
Withdrawal Assessment Scale (WAS).33 34
The three phases of sedation (acute, plateau and
weaning) management were derived from patterns
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observed in a retrospective audit conducted earlier by
the research team35 36 and from the literature.9 12 37–39
The guidelines reﬂect the dynamic nature of a PICU
patient’s admission and allow for movement between
and within phases according to the patient’s need,
response and condition.
As the main aim of the guidelines was to improve con-
sistency in medication practices, it was vital to get a con-
sensus on prescribing practices within the study units.
Even the authors of the consensus guidelines noted that
there was limited evidence to draw on and the recom-
mendations were based on knowledge of drug pharma-
cokinetics, case study reports, expert opinion and also
the understanding of pain management, drug tolerance
and withdrawal medicine. Morphine and midazolam are
the most common analgesic and sedative agents used in
PICUs3 14 35 40 and the drugs of choice in the study
units. They are typically used in combination as together
they have a synergistic effect that often allows for use of
lower doses. Midazolam doses can be reduced as much
as 30–50% when combined with an opioid.41
Nonetheless, prolonged and/or heavy sedation persists
in critical care units, and as a result tolerance and with-
drawal syndrome complicate recovery.
In the acute phase, the guidelines proposed a signiﬁ-
cant loading dose to achieve the desired analgesia and
sedation goals, followed by regular patient assessment
and incremental medication changes to achieve and
maintain these goals. If the maximum dose allowed was
reached (ie, 300 μg/kg/h for the past 4 h), then use of
adjunct or alternative drugs was recommended (ie, clo-
nidine, fentanyl). ‘Drug cycling’ has been reported to
be helpful in the UK, where 25% of PICUs surveyed
reported rotation of sedatives to minimise tolerance.3 In
another paper, consultant intensivists conducted
biweekly chart reviews of each patient in the ICU and
regularly changed their sedation regimens.42 Although
these authors imply success with drug tolerance, no
numerical data was offered in support.
Once in the plateau phase, the key change in practice
was the recommended conversion from intravenous to
long-acting enteral agents. This approach is based on
the principles of narcotic withdrawal where withdrawal
syndrome is managed by conversion to an orally active
drug with a longer half-life (such as methadone or
diazepam) that has a more steady state serum concentra-
tion, more readily facilitating a slow tapering of the drug
and minimising the severity of withdrawal symptoms or
Table 1 Summary of 2006 consensus paper recommendations for sedation management of critically ill children
1. Non-pharmacological interventions i. Any correctable environmental and physical factors causing discomfort should
be addressed alongside the introduction of pharmacological agents
ii. A normal pattern of sleep should be encouraged. Attention should be paid to
lighting, environmental noise and temporal orientation of patients
2. Pain assessment and analgesic
management
i. All critically ill children have the right to adequate relief of their pain. Local and
regional anaesthetic techniques should be considered. A patient controlled
analgesia (PCA) device may be useful in older children
ii. Pain assessment should be performed regularly by using a scale appropriate to
the age of the patient and routinely documented. The level of pain reported by
the patient must be considered the current standard of analgesia. Patients who
cannot communicate should be assessed for the presence of pain-related
behaviours and physiological indicators of pain. A therapeutic plan for analgesia
should be established for each patient and regularly reviewed
iii. Recommended pharmacological agents for analgesia include opioids (eg,
morphine, fentanyl) for the relief of severe pain, non-steroidal anti-inflammatory
drugs (NSAIDs) for moderately severe pain, and paracetamol for mild to
moderate pain
3. Sedation assessment and
recommended or commonly used
sedative agents
i. Adequate analgesia should be provided to all critically ill children regardless of
the need for sedation. The use of clinical guidelines for sedation is
recommended
ii. The level of sedation should be regularly assessed and documented using a
validated and age-appropriate sedation assessment scale. The desired level of
sedation should be identified for each patient and regularly reassessed. Doses
of sedative agents should be titrated to produce the desired level of sedation
iii. Recommended pharmacological agents for sedation include midazolam or
clonidine. Early use of enteral sedative agents (eg, chloral hydrate,
promethazine) is recommended. Propofol should not be used to provide
continuous sedation in critically ill children
4. Withdrawal syndrome assessment,
prevention and management
i. The potential for opioid and benzodiazepine withdrawal syndrome should be
considered after 7 days of continuous therapy
ii. When subsequently discontinued, the doses of these agents may need to be
routinely tapered
Keogh SJ, et al. BMJ Open 2015;5:e006428. doi:10.1136/bmjopen-2014-006428 3
Open Access
group.bmj.com on August 21, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
even development of the withdrawal syndrome.43–46 The
advantages of methadone are an oral bioavailability of
75–80%, allowing for oral administration, and a pro-
longed half-life of 12–24 h, allowing twice daily adminis-
tration (ibid). There is a general reluctance to use
diazepam for critically ill patients because of its long
elimination and concerns about excessive and pro-
longed sedation. However, similar to methadone, diaze-
pam’s long-acting active metabolites theoretically should
result in small changes in serum drug concentrations
and may decrease ﬂuctuations in sedation state and
therefore be a more appropriate agent for long-term
sedated patients.39
The formal acknowledgement of a sedation weaning
phase with a dedicated assessment tool and tapering
regime was new practice for the study units. No validated
opioid or benzodiazepine weaning schedule was found;
however, a consensus of opinion across the literature
supports a daily reduction of 5–10% or an initial reduc-
tion of 20–40%, followed by a 10% reduction once or
twice daily, depending on the patient response.39 47 The
protocol for sedation weaning incorporated into these
guidelines approximated these recommendations.
Guideline implementation
The guidelines encompassed many changes in practice:
new assessment scales, standardisation of practice, con-
version to oral agents, algorithms and a discreet weaning
pathway. In the interest of maximising staff understand-
ing and uptake of the tools, a phased implementation
process was adopted with the gradual introduction of
each tool into the units, followed by orientation and
implementation of the algorithm phases and medication
administration. Staff in-services introducing the study
and guidelines were held over an initial fortnight with
phased introduction and implementation of each assess-
ment tool over the following months. These were
further supported by bedside education on tool use and
supplemented by information and teaching aids on the
units’ computer system.
In practice, the PICU team set sedation and analgesia
goals as part of the daily patient review and staff at the
bedside (usually nurses) used the guidelines to achieve
the set goals.
Outcome variables
Data were collected from all eligible patients over
24 months (12 months historical control and 12 months
post-implementation), plus a break to allow for the
implementation period. In addition to the main study
outcomes, the pilot study collected outcomes to establish
feasibility of the protocol and processes. The main study
outcomes measured included total ventilation time
(TVT), sedation doses and duration, LOS in the PICU,
plus quality indicators, such as accidental extubation
and readmission rates. It was important to establish that
the outcomes were not adversely affected by the guide-
lines before considering larger and more extensive trial
work. Feasibility data outcomes included the success of
screening and recruitment strategies; data collection and
entry processes; conﬁrmation of Research Nurse time
and cost, and produced further estimates of ventilation
times and medication dosing, which can be used to
ﬁnalise sample size requirements for the larger trial, and
inform funding applications for same. Potentially con-
founding variables collected included patient age,
gender, diagnosis and the Paediatric Index of Mortality
(PIM2) as a measure of acuity. Nurses in the study
setting routinely collect and record standard demo-
graphic and biophysiological patient measurements on
the local computerised information system. The revised
PIM2 is a simple model of mortality in PICU based on
admission data and uses 10 explanatory variables.48
Post-implementation compliance/ﬁdelity was assessed by
chart review using an audit tool based on the 19 key
components of the guidelines. Adherence to 75% of the
key components overall and then within each phase was
nominally chosen as the minimum acceptable value for
ﬁdelity at this stage. However, the results whatever they
were would inform any future implementation processes
and trial work. Nursing staff perceptions of the guide-
lines were ascertained through administration of a
researcher-developed survey with questions on ease of
use, impact on practice, perceived beneﬁt, facilitation of
team management and promotion of nurse autonomy at
the bedside. Staff members were also given the oppor-
tunity to comment on strengths and limitations of the
guidelines.
Statistical analysis
Data were analysed using PASW V.18.0 (SPSS Inc.).
Descriptive statistics were used for demographic data.
Continuous values reported were medians and ranges
due to the large spread of the data. Categorical variables
were reported as counts and percentages.
Non-parametric Mann-Whitney or Cross tabulation and
Pearson’s χ2 were performed to compare groups. The
probability of remaining ventilated between groups was
analysed using survival analysis. Adherence to guidelines
was reported in counts and percentages. The inﬂuence
of diagnostic group on guideline adherence was ana-
lysed using Pearson’s correlation and comparison of
means using Student t test. Survey responses were
reported in counts and percentages as well as signiﬁcant
themes derived from qualitative data.
RESULTS
During the two study periods (12 months each), 173
and 235 patients were ventilated in the respective pregui-
deline and postguideline implementation periods. After
screening for eligibility, 75 and 70 patients were enrolled
into the pre and post groups. Seven patients were lost to
the study in the post-test group because of deviation
from research protocol (n=5), one group of parents did
not consent to use the drugs, and one was transferred to
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another hospital. Ultimately, there were 75 in the
control group and 63 in the post-implementation group.
Data were analysed on a per-protocol basis. Figure 1
demonstrates the sampling framework and exclusion
criteria.
Table 2 shows the main characteristics measured for
each sample. Both groups were comparable with no sig-
niﬁcant differences between age, weight, sex or reason
for admission. There were also no differences identiﬁed
between the TVT and LOS for each group. There were
no incidents of accidental extubation or readmission
within 48 h for participants in either group for the study.
Table 3 shows the different drug characteristics
between groups, demonstrating a greater variance in
drug usage. The decrease of 19 h in the median infusion
time of morphine between groups approached signiﬁ-
cance (87 vs 68 h, p=0.059). There were changes in the
median minimum and maximum morphine doses,
though not signiﬁcantly. A reduction of 11 h was identi-
ﬁed with median infusion of midazolam between groups;
however, this difference was not signiﬁcant. Signiﬁcant
changes in the median minimum and maximum doses of
midazolam were observed (minimum 10 vs 17 μg/kg/h,
p<0.001 and maximum 120 vs 180 μg/kg/h, p<0.001).
Applying the Kaplan-Meier curve of risk to the prob-
ability of remaining ventilated to each group demon-
strated that the post-test group did not have an
increased risk of remaining ventilated (see ﬁgure 2).
Figure 1 Sample framework (adm, admission; excl, exclusion; incl, inclusion).
Table 2 Baseline characteristics in the study groups
Pre, n=75 Post, n=63 Statistic
Age (years), median (IQR) 2.08 (5.6) 1.75 (4.5) NS
Mann-Whitney
Weight (kg), median (IQR) 11.5 (15.62) 12 (11) NS
Mann-Whitney
Sex, N (%) Male, 45 (60%) Male, 38 (60%) NS
χ2
Primary diagnosis, N (%) Resp, 29 (39%) Resp, 21 (33%) NS
χ2
PIM, median (IQR) 5.00 (9) 5.20 (5.3) NS
Mann-Whitney
TVT (days), median (IQR) 4.02 (5.36) 3.12 (7.68) NS
Mann-Whitney
LOS (days), median (IQR) 6.3 (6.76) 5.8 (7.90) NS
Mann-Whitney
NS=not statistically significant, that is, p≥0.05.
LOS, length of stay; PIM, Paediatric Index of Mortality; TVT, total ventilation time.
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The probability of remaining ventilated was reduced in
the post-test group (by just less than a day at 21 h);
however, this was not statistically signiﬁcant.
Other observed changes in practice were the greater
use of adjunctive and alternative medication, in particu-
lar methadone. Results showed that, prior to the guide-
line implementation, there was limited use of alternative
medications (1–2 alternative medications or even none).
Post-guideline implementation the numbers of alterna-
tive medications used increased. A more detailed ana-
lysis revealed a signiﬁcant difference with the use of
methadone pre 3%—post 33%, p<0.001; diazepam pre
5%—post 25%, p=0.001; chloral hydrate pre 32%—post
58%, p=0.002; propofol pre 60%—post 20%, p<0.001;
and neuromuscular blockade agents pre 60%—post
47.6%, not signiﬁcant.
Implementation fidelity (chart audit)
Sixty-three charts from the post-implementation period
were reviewed to identify the level of staff adherence to
the 19 key components of the guidelines and quantify
the level of assessment and scoring. Overall adoption
was achieved in 23 (36%) of the charts audited.
Separate analysis within each of the phases demon-
strated that adoption was achieved in 30 (47.6%) in the
acute phase, 23 (36.5%) in the plateau phase and 25
(39.7%) in the weaning phase. Pain and sedation scores
were assessed and documented in 95% (n=60) of charts
in the acute and plateau phases, and in 85% (n=54) of
charts in the weaning phase. The withdrawal score was
assessed and documented appropriately in 75% (n=47)
of charts.
Staff survey
The response rate was 49% (n=54). Participants’
responses were divided into four categories: awareness/
use, strengths, limitations and suggestions for improve-
ment. Fifty-two (96%) respondents stated they regularly
referred to the guideline to assist with decision-making
and to provide prompts and cues. There appeared to be
some confusion as to who was primarily responsible for
the initiation of the guidelines, with 12 (23%) suggest-
ing that it is was the consultant’s responsibility and 32
(60%) stating that it was the responsibility of the bedside
nurse. Table 4 outlines further responses.
The perceived strengths of the tool included the struc-
tured nature of the guidelines, promotion of consistency
in practice and the resulting increased awareness regard-
ing sedation management. Conversely, the perceived lim-
itations included the perceived complexity of algorithm,
confusion with delineation and movement between
phases, and the lack of accommodation of increased
drug tolerance with long-term patients. Staff suggested
simplifying the algorithm and using larger print, incorp-
orating recommendations for short-term patients and
providing clinical example as guides. Box 1 provides a
sample of staff comments on the perceived strengths
and weaknesses of the guidelines. Overall, four major
themes were expressed by study participants (see box 1):
(1) a knowledge deﬁcit about some aspects of the
Table 3 Outcome variable comparison between study groups
Pre, n=75
Median (IQR)
Post, n=63
Median (IQR) Difference and statistic
Morphine
Infusion duration (h) 87 (136.5) 68 (78) −19 h p=0.059
Minimum dose (μg/kg/h) 10 (11) 17 (10) +7 μg /kg/h NS
Maximum dose (μg/kg/h) 120 (102.25) 97.5 (52.75) −22.5 μg /kg/h NS
Midazolam
Infusion duration (h) 71 (154) 60 (90) −11 h NS
Minimum dose (μg /kg/h) 10 (12) 24 (20) +14 μg/kg/h p<0.001
Maximum dose (μg/kg/h) 120 (101.75) 180 (143.25) +60 μg/kg/h p<0.001
NS=not statistically significant, that is, p≥0.05.
Figure 2 Kaplan-Meier curve of risk of remaining ventilated
between groups.
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guidelines, (2) high value placed on individualised
patient care, (3) perceived ineffectiveness of the guide-
lines for some patients and (4) disagreement between
doctors and nurses on responsibilities.
DISCUSSION
This pragmatic pilot study demonstrated the use of
guideline-directed sedation and analgesia management
was not associated with increased ventilation times or
PICU LOS. The results of the study also showed that the
guidelines were generally feasible and acceptable in clin-
ical practice with predominantly positive feedback from
nursing staff using them. Full adoption of all aspects of
guidelines was not realised, but results demonstrated
improved levels of patient assessment and increased use of
enteral agents (in line with guideline recommendations).
The observed increases in median minimum and
maximum doses of morphine and midazolam do not
appear to be associated with an increase in patient TVT
or LOS, and in fact the duration of each infusion was
reduced. Similar changes in medication administration
have been observed in other PICU guideline studies.16–20
The results of the Kaplan-Meier Risk analysis indicate
that there was potentially a reduced risk of remaining venti-
lated in the post-test group (though this was not statistically
signiﬁcant). However, a median difference of 21 h between
groups may be viewed as ‘clinically signiﬁcant’ as this time
difference in the clinical setting could translate to earlier
extubation and/or discharge. Larger randomised trial
studies are warranted to allow ﬁrm conclusions to be made.
Only a small proportion of participants were ultimately
eligible for the study (43% and 31%, respectively),
which has implications for the projected timeline,
research assistant time and costs and data collection for
a larger multisite trial. The results also revealed the
huge spread of the clinical data and the challenge this
posed for researchers. Follow-on studies would possibly
need to consider subcategories of patients, that is, short-
term, medium-term and long-term ventilated, and
analyse them within these categories.
The guidelines and implementation process in this
study also appear to have increased the awareness and
usage of alternative medications to complement or
replace morphine/midazolam. This was particularly
evident with the use of methadone and diazepam. Use
of methadone rose from 3% pretest to 33% post-test.
Use of diazepam rose from 5% pretest to 25% post-test.
One of the key recommendations to emerge from the
literature, and therefore included in the guidelines, was
the transition from continuous intravenous analgesia
and sedation to regular oral agents. Prolonged adminis-
tration of opioids and benzodiazepines may result in the
development of drug tolerance and then withdrawal syn-
drome if these agents are abruptly discontinued.9 38 49 50
Research has shown that this can be prevented by slowly
tapering the intravenous administration of the drug or
switching from intravenous morphine and midazolam to
orally active drugs with a longer half-life, such as metha-
done and diazepam.44 46 In general, the increased use
of adjunct medication was evidence of the clinician’s use
of guideline recommendations.
Sedation, Pain and Withdrawal scores were all cap-
tured but difﬁcult to summarise meaningfully as a
Table 4 Staff perceptions of sedation guidelines in
practice
Questions
Yes
response
n=54 (%)
The sedation guidelines and flow chart are
easy to follow
58.5
The flow chart facilitates the sedation
management process
87
Patients benefit from having a constructive
escalation programme
96.3
Patients benefit from having a constructive
titration programme
94.3
Patients benefit from having a constructive
weaning programme
96.2
A multidisciplinary approach enhances
sedation management
96.3
The guidelines give me more autonomy in
managing sedation
68.5
The guidelines improve overall sedation
management
88.5
Box 1 Staff perceptions of strengths and limitations of
sedation guidelines
Strengths
▸ The bedside nurse ‘knows’ the patient and their requirements,
can initiate changes, use objective data on the screen, see
changes and ask for a review if needed
▸ It is a clinical tool to justify an increase or decrease in sed-
ation. Allows for uniform/consistent decision-making
▸ Empowers and rationalises nursing changes in sedation
▸ Everyone using the same guide should translate to more con-
sistent care. There is more autonomy for nurses, particularly
with less experienced registrars. It potentially irons out varia-
tions in individual consultant preferences
▸ It has increased the awareness among staff and prompts
discussion
▸ It places importance on sedation and assists nurses to provide
better sedation. Patients more comfortable equals parents
more comfortable
Limitations
▸ Can be complicated because of the amount of detail
▸ Needs definitions and differential diagnoses for each of the
phases
▸ Not all patients fit the guidelines or respond as predicted
▸ Requires full concentration with attention to detail and practice
to become familiar
▸ Lack of medical leadership/ownership shared
▸ Difficult to continue in ward, particularly with weaning
▸ Have trouble with some long-term patients following the
guidelines and keeping them comfortable
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research variable. We recommended that a useful vari-
able for follow-up in studies would be to calculate the
percentage of time each patient spent in a designated
‘zone’ and determining the appropriateness and
success/failure of management accordingly.
The audit of implementation ﬁdelity demonstrated
that the assessment and documentation of patient’s pain
and sedation was well recorded, reﬂecting sound staff
understanding and uptake of the new assessment tools.
The adoption score for the withdrawal phase was the
lowest of the three phases, which may have resulted from
less familiarity and knowledge with the tool and phase.
This is consistent with ﬁndings found in a review of
similar studies.51 Suggested reasons for non-adherence
included complexity of the guideline or algorithm, staff
not valuing or understanding the goal of the guideline
and perceived redundancy of the guideline if the staff
were already competent practitioners in this area (ibid).
Potential solutions to these issues included ongoing staff
education and timely feedback related to the guideline to
continuously reinforce importance, ease of use and
troubleshoot issues.52 In addition to surveying staff
opinion, it is also important to conduct periodic chart
audits to quantify guideline ﬁdelity. This will help minim-
ise self-report bias as was reﬂected somewhat in this
study.53 Staff perceptions of guideline principles and use
were positive, although the level of adherence was vari-
able. So the full impact of the guidelines was not realised.
In conjunction with the audit, a survey of nursing staff
perceptions and attitudes was undertaken to establish if
these inﬂuenced adoption of the guidelines. In line with
other similar studies, nurses were largely positive and
constructive in their feedback.18 16 54 All feedback has
been utilised to improve the guidelines. Involving staff
and providing feedback during the process of proced-
ural change is a vital step in optimising follow trial
success and ultimately translation to practice. Follow-on
trials should also build in mechanisms to capture multi-
disciplinary staff experience and feedback.
The importance of the ﬁndings of this study is that
they indicate that collaborative guidelines can be used to
manage the PICU patient’s comfort and pain without
compromising quality of care (TVT, LOS, quality indica-
tors). The results are similar to those in the adult popu-
lation where guideline or protocol-driven sedation has
been linked to a reduction in duration of continuous
intravenous sedation, ventilation time and associated
healthcare costs.55–59 Evaluation of feasibility outcomes
has aided in the development of a realistic plan regard-
ing participant recruitment, staff education to optimise
guideline ﬁdelity, safety of guidelines in clinical practice
and collection of key outcome variables.
IMPLICATIONS AND RECOMMENDATIONS
No deﬁnitive causal effect can be attributed to the guide-
lines on outcomes due to the pre–post study design and
small sample size. Full adoption of all phases and tools in
the guidelines was not realised and this has implications
for ongoing implementation and larger trial work.
Additionally, the small response rate and selective popula-
tion for the survey may introduce some bias in the
current understanding of staff acceptance of the guide-
lines. A more inclusive (medical and nursing) survey
population is recommended for follow-up research.
Conducting the study in two units assists with the general-
isability of the study and its results. Some speciﬁcs of the
guidelines and algorithm, however, might need modiﬁca-
tion to reﬂect local practice, for example, use of different
drugs (fentanyl instead of morphine) and different
patient populations (post cardiothoracic surgery).
The study results are most useful in informing the
structure and outcome measures for a follow-on clinical
trial in this area.
Results from the study, audit and survey have informed
changes and modiﬁcations to optimise staff understand-
ing and use of sedation guidelines in practice. Weaning
from sedation agents and the concept of withdrawal
appear to be areas of practice that need more attention.
The researchers went on to trial and evaluate a revised
withdrawal assessment tool and a study comparing the
outcomes of dexmedetomidine versus midazolam is
about to start. The study units plan to continue to use
the guidelines and tools in their modiﬁed form pending
the results of a larger trial work recently completed
in the USA. The modern ICU is an important focus for
quality improvement efforts. Guidelines cannot automat-
ically guarantee improved quality of care; however, they
do direct the clinician in the pursuit of this objective,
particularly when supported by high-level evidence.
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